Viewing Study NCT06540066


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2025-12-25 @ 2:23 PM
Study NCT ID: NCT06540066
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-08-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors
Sponsor: BeiGene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module